Referred to the Committee on Energy and Commerce, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
H.R. 3676 converts Executive Order 14293 into permanent federal law, codifying the president's directive to streamline regulations in order to boost domestic production of critical medicines in the United States. The bill affects pharmaceutical manufacturers, regulatory agencies like the FDA, and ultimately patients who depend on reliable access to essential medications. By converting an executive order into statute, the legislation makes these regulatory relief measures binding on future administrations and more difficult to reverse through executive action alone. The bill was introduced in June 2025 and referred to both the Energy and Commerce Committee and the Transportation and Infrastructure Committee for review, though no specific funding amounts or implementation timelines are detailed in the legislation text provided.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.